O'Byrne K - Search Results

1

The MyD88+ phenotype is an adverse prognostic factor in epithelial ovarian cancer.

d'Adhemar CJ, Spillane CD, Gallagher MF, Bates M, Costello KM, Barry-O'Crowley J, Haley K, Kernan N, Murphy C, Smyth PC, O'Byrne K, Pennington S, Cooke AA, Ffrench B, Martin CM, O'Donnell D, Hennessy B, Stordal B, Finn S, McCann A, Gleeson N, D'Arcy T, Flood B, O'Neill LA, Sheils O, O'Toole S, O'Leary JJ. d'Adhemar CJ, et al. PLoS One. 2014 Jun 30;9(6):e100816. doi: 10.1371/journal.pone.0100816. eCollection 2014. PLoS One. 2014. PMID: 24977712 Free PMC article.

2

Gene expression analysis of diagnostic biopsies predicts pathological response to neoadjuvant chemoradiotherapy of esophageal cancer.

Maher SG, Gillham CM, Duggan SP, Smyth PC, Miller N, Muldoon C, O'Byrne KJ, Sheils OM, Hollywood D, Reynolds JV. Maher SG, et al. Ann Surg. 2009 Nov;250(5):729-37. doi: 10.1097/SLA.0b013e3181bce7e1. Ann Surg. 2009. PMID: 19801928

3

The role of inflammation in the pathogenesis of non-small cell lung cancer.

O'Callaghan DS, O'Donnell D, O'Connell F, O'Byrne KJ. O'Callaghan DS, et al. J Thorac Oncol. 2010 Dec;5(12):2024-36. doi: 10.1097/jto.0b013e3181f387e4. J Thorac Oncol. 2010. PMID: 21155185 Free article. Review.

4

Epigenetics underpinning the regulation of the CXC (ELR+) chemokines in non-small cell lung cancer.

Baird AM, Gray SG, O'Byrne KJ. Baird AM, et al. PLoS One. 2011 Jan 27;6(1):e14593. doi: 10.1371/journal.pone.0014593. PLoS One. 2011. PMID: 21298036 Free PMC article.

5

Receptor tyrosine kinases and their activation in melanoma.

Easty DJ, Gray SG, O'Byrne KJ, O'Donnell D, Bennett DC. Easty DJ, et al. Pigment Cell Melanoma Res. 2011 Jun;24(3):446-61. doi: 10.1111/j.1755-148X.2011.00836.x. Epub 2011 Mar 3. Pigment Cell Melanoma Res. 2011. PMID: 21320293 Review.

6

Examination of thromboxane synthase as a prognostic factor and therapeutic target in non-small cell lung cancer.

Cathcart MC, Gately K, Cummins R, Kay E, O'Byrne KJ, Pidgeon GP. Cathcart MC, et al. Mol Cancer. 2011 Mar 9;10:25. doi: 10.1186/1476-4598-10-25. Mol Cancer. 2011. PMID: 21388528 Free PMC article.

7

Circulating tumour cells, their role in metastasis and their clinical utility in lung cancer.

O'Flaherty JD, Gray S, Richard D, Fennell D, O'Leary JJ, Blackhall FH, O'Byrne KJ. O'Flaherty JD, et al. Lung Cancer. 2012 Apr;76(1):19-25. doi: 10.1016/j.lungcan.2011.10.018. Epub 2011 Dec 29. Lung Cancer. 2012. PMID: 22209049 Review.

8

The cancer stem-cell hypothesis: its emerging role in lung cancer biology and its relevance for future therapy.

O'Flaherty JD, Barr M, Fennell D, Richard D, Reynolds J, O'Leary J, O'Byrne K. O'Flaherty JD, et al. J Thorac Oncol. 2012 Dec;7(12):1880-1890. doi: 10.1097/JTO.0b013e31826bfbc6. J Thorac Oncol. 2012. PMID: 23154562 Free article. Review.

9

Generation and characterisation of cisplatin-resistant non-small cell lung cancer cell lines displaying a stem-like signature.

Barr MP, Gray SG, Hoffmann AC, Hilger RA, Thomale J, O'Flaherty JD, Fennell DA, Richard D, O'Leary JJ, O'Byrne KJ. Barr MP, et al. PLoS One. 2013;8(1):e54193. doi: 10.1371/journal.pone.0054193. Epub 2013 Jan 17. PLoS One. 2013. PMID: 23349823 Free PMC article.

10

Predictive values for molecular diagnostics: converting unknown unknowns to known unknowns.

O'Brien CP, Langabeer SE, O'Byrne KJ, O'Leary JJ, Finn SP. O'Brien CP, et al. Mol Diagn Ther. 2014 Feb;18(1):1-4. doi: 10.1007/s40291-013-0076-x. Mol Diagn Ther. 2014. PMID: 24338436 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

567 results

Search Page